Overview
Metastatic colorectal cancer often spreads to distant organs, creating a need for treatment strategies that combine systemic drug therapies with direct interventions, such as surgery or ablation, aimed at eliminating individual metastases. Known as metastasis-directed therapy (MDT), this approach can help control disease spread, but real-world practices across different countries and healthcare systems are poorly characterized.
Using the Flatiron Health Research Database, researchers evaluated 4,255 patients with metastatic colorectal cancer across Germany, Japan, and the United Kingdom between 2016 and 2025. The study found that MDT was used significantly more often in Germany (51%) and Japan (40%) than in the UK (21%). Furthermore, clinicians in Germany and Japan more frequently performed MDT upfront before transitioning to targeted drug therapies, whereas UK clinicians relied more heavily on chemotherapy first before considering local interventions.
Why this matters
This research highlights international differences in how doctors approach the treatment of spreading colorectal cancer. By illuminating these regional practice patterns, the study provides valuable insights that can help guide global treatment standards, optimize the timing of surgical interventions, and improve care strategies for patients with cancer.